Connect with us

INDUSTRIAL HEMP

What Is The Buzz Surrounding Biogen Inc (NASDAQ:BIIB)?

Published

on

Biogen Inc (NASDAQ:BIIB) has appointed Chirfi Guindo as EVP and Head of Global Marketing, Market Access & Customer Innovation. Mr. Guindo will lead company’s international functions of Marketing and Asset Teams, Customer Innovation and Market Access. He will report to Mr. Michel Vounatsos, the CEO of Biogen, and will be a part of the Executive Committee. His appointment becomes effective November 7, 2017.

The details

Mr. Guindo has extensive experience of 27 years in the international pharmaceutical industry and has held numerous leadership positions at Merck in the USA, France, Canada, Africa and the Netherlands. He served in distinct disciplines including Sales & Marketing, Finance, Global Strategy/Product Development and General Management. Most recently he was Managing Director and President of Merck Canada.

Commenting on his new role with Biogen, Mr. Guindo expressed that he is delighted to be a part of company. Biogen comes in the list of the oldest independent biotech firms, and is widely known for its expertise in curing neurological diseases. He considers that his extensive experience offers him a different perspective that will enable him to identify prospects where Biogen can offer better value to patients, customers and society.

Mr. Vounatsos, the CEO of Biogen, expressed that he is thrilled to welcome Chirfi who is a seasoned international pharmaceutical pioneer in their industry. He looks forward to associating with him as they further Biogen’s leadership in SMA and MS, strategize for company’s Alzheimer’s disease franchise and target future pipeline opportunities.

Biogen is a pioneer in neuroscience. It discovers, develops and delivers global unique therapies for people struggling with serious neurodegenerative and neurological diseases. Founded in 1978 by Charles Weissman, Phillip Sharp and Walter Gilbert, today the company has the leading portfolio of drugs to cure multiple sclerosis; has launched the first and only permitted treatment for spinal muscular atrophy.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure

BRANDS

DETAILS

SCORE

PRODUCT SITES

  • Certified Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49

9.8

30% OFF Today! “30 0FF”

  • All Natural
  • Made In U.S.A
  • Lab Tested
  • Price From $69

9.7

  • All Natural
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99

9.6

  • All Natural
  • Made In U.S.A
  • Oral Mist
  • Price From $39

9.5

BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Purity Promise
  • Price From $49
SCORE

9.8

PRODUCT SITE
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Lab Tested
  • Price From $69
SCORE

9.7

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Dissolvable Oral
  • Price From $99
SCORE

9.6

PRODUCT SITE VIEW PRODUCTS
BRAND
DETAILS
  • All Organic
  • Made In U.S.A
  • Oral Mist
  • Price From $39
SCORE

9.5

PRODUCT SITE VIEW PRODUCTS
Advertisement
Advertisement

Symbol        Alert        High        Gain

 

  VBIO          $0.67       $4.10      500%

  IMLFF        $0.11       $0.57      400%

  CMXC        $0.25       $0.45      80%

  REPCF       $0.54       $0.79      48%

 

Get Your Latest Winner Delivered to Your Inbox!

FREE

For The Next 48 Hours

Advertisement
Advertisement
Advertisement
Advertisement
Advertisement